Cargando…

Exploiting the Nucleic Acid Nature of Aptamers for Signal Amplification

Aptamer-based assays and sensors are garnering increasing interest as alternatives to antibodies, particularly due to their increased flexibility for implementation in alternative assay formats, as they can be employed in assays designed for nucleic acids, such as molecular aptamer beacons or aptame...

Descripción completa

Detalles Bibliográficos
Autores principales: Jauset-Rubio, Miriam, Ortiz, Mayreli, O’Sullivan, Ciara K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688535/
https://www.ncbi.nlm.nih.gov/pubmed/36354481
http://dx.doi.org/10.3390/bios12110972
_version_ 1784836292912087040
author Jauset-Rubio, Miriam
Ortiz, Mayreli
O’Sullivan, Ciara K.
author_facet Jauset-Rubio, Miriam
Ortiz, Mayreli
O’Sullivan, Ciara K.
author_sort Jauset-Rubio, Miriam
collection PubMed
description Aptamer-based assays and sensors are garnering increasing interest as alternatives to antibodies, particularly due to their increased flexibility for implementation in alternative assay formats, as they can be employed in assays designed for nucleic acids, such as molecular aptamer beacons or aptamer detection combined with amplification. In this work, we took advantage of the inherent nucleic acid nature of aptamers to enhance sensitivity in a rapid and facile assay format. An aptamer selected against the anaphylactic allergen β-conglutin was used to demonstrate the proof of concept. The aptamer was generated by using biotinylated dUTPs, and the affinity of the modified aptamer as compared to the unmodified aptamer was determined by using surface plasmon resonance to calculate the dissociation constant (K(D)), and no significant improvement in affinity due to the incorporation of the hydrophobic biotin was observed. The modified aptamer was then applied in a colorimetric competitive enzyme-linked oligonucleotide assay, where β-conglutin was immobilized on the wells of a microtiter plate, competing with β-conglutin free in solution for the binding to the aptamer. The limit of detection achieved was 68 pM, demonstrating an improvement in detection limit of three orders of magnitude as compared with the aptamer simply modified with a terminal biotin label. The concept was then exploited by using electrochemical detection and screen-printed electrodes where detection limits of 326 fM and 7.89 fM were obtained with carbon and gold electrodes, respectively. The assay format is generic in nature and can be applied to all aptamers, facilitating an easy and cost-effective means to achieve lower detection limits.
format Online
Article
Text
id pubmed-9688535
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96885352022-11-25 Exploiting the Nucleic Acid Nature of Aptamers for Signal Amplification Jauset-Rubio, Miriam Ortiz, Mayreli O’Sullivan, Ciara K. Biosensors (Basel) Article Aptamer-based assays and sensors are garnering increasing interest as alternatives to antibodies, particularly due to their increased flexibility for implementation in alternative assay formats, as they can be employed in assays designed for nucleic acids, such as molecular aptamer beacons or aptamer detection combined with amplification. In this work, we took advantage of the inherent nucleic acid nature of aptamers to enhance sensitivity in a rapid and facile assay format. An aptamer selected against the anaphylactic allergen β-conglutin was used to demonstrate the proof of concept. The aptamer was generated by using biotinylated dUTPs, and the affinity of the modified aptamer as compared to the unmodified aptamer was determined by using surface plasmon resonance to calculate the dissociation constant (K(D)), and no significant improvement in affinity due to the incorporation of the hydrophobic biotin was observed. The modified aptamer was then applied in a colorimetric competitive enzyme-linked oligonucleotide assay, where β-conglutin was immobilized on the wells of a microtiter plate, competing with β-conglutin free in solution for the binding to the aptamer. The limit of detection achieved was 68 pM, demonstrating an improvement in detection limit of three orders of magnitude as compared with the aptamer simply modified with a terminal biotin label. The concept was then exploited by using electrochemical detection and screen-printed electrodes where detection limits of 326 fM and 7.89 fM were obtained with carbon and gold electrodes, respectively. The assay format is generic in nature and can be applied to all aptamers, facilitating an easy and cost-effective means to achieve lower detection limits. MDPI 2022-11-04 /pmc/articles/PMC9688535/ /pubmed/36354481 http://dx.doi.org/10.3390/bios12110972 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Jauset-Rubio, Miriam
Ortiz, Mayreli
O’Sullivan, Ciara K.
Exploiting the Nucleic Acid Nature of Aptamers for Signal Amplification
title Exploiting the Nucleic Acid Nature of Aptamers for Signal Amplification
title_full Exploiting the Nucleic Acid Nature of Aptamers for Signal Amplification
title_fullStr Exploiting the Nucleic Acid Nature of Aptamers for Signal Amplification
title_full_unstemmed Exploiting the Nucleic Acid Nature of Aptamers for Signal Amplification
title_short Exploiting the Nucleic Acid Nature of Aptamers for Signal Amplification
title_sort exploiting the nucleic acid nature of aptamers for signal amplification
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688535/
https://www.ncbi.nlm.nih.gov/pubmed/36354481
http://dx.doi.org/10.3390/bios12110972
work_keys_str_mv AT jausetrubiomiriam exploitingthenucleicacidnatureofaptamersforsignalamplification
AT ortizmayreli exploitingthenucleicacidnatureofaptamersforsignalamplification
AT osullivanciarak exploitingthenucleicacidnatureofaptamersforsignalamplification